La SFV
Actions
Special Covid-19
Actualités
Ressources
- Portraits de virus
- Traité de Virologie Médicale
Contact
- Abonnez-vous à nos listes de diffusion
- Contact

La SFV
Actions
Special Covid-19
Actualités
Ressources
- Portraits de virus
- Traité de Virologie Médicale
Contact
- Abonnez-vous à nos listes de diffusion
- Contact

Le variant du SARS-CoV-2 sous les projecteurs

décembre 22, 2020

L’encre coule, les scénarios vont bon train, qu’en est-il du variant VUI-202012/01 ? Cliquer sur le lien pour accéder au communiqué du 18 décembre 2020 :
New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)

Articles Récents

Institut Cochin2

Three years post-doctoral position on the contribution of Autophagy proteins in HIV replication

janvier 20, 2021henri.gruffat

Post-doctoral position on SARS-CoV-2 and the male genital tract

janvier 13, 2021henri.gruffat

TWO POSTDOC POSITIONS AVAILABLE HOST PATHOGEN INTERACTION IN LENTIVIRAL INFECTION LABORATORY AT THE CIRI, LYON, FRANCE

janvier 11, 2021henri.gruffat

Fil Twitter de la SFV

Societe Francaise De VirologieFollow

Retweet on Twitter Societe Francaise De Virologie Retweeted

Avatar Áine O'Toole @AineToole·

Updated SARS-CoV-2 lineage of concern report for 2021-01-20 available at https://cov-lineages.org/global_report.html
@arambaut @viralverity @EvolveDotZoo @MOUGK @edwardcholmes

Reply on Twitter 1351963711586578432 Retweet on Twitter 135196371158657843218 Like on Twitter 135196371158657843231 Twitter 1351963711586578432

Retweet on Twitter Societe Francaise De Virologie Retweeted

Avatar NIDO2021 @NIDO20201·

The symposium on coronaviruses and related viruses, will take place online from The Netherlands on June 7-8 this year. Check out the website http://nido2021.nl regularly, in February calls for abstracts and registration opens! @bart_haagmans @MarionKoopmans

Reply on Twitter 1351963835209494538 Retweet on Twitter 13519638352094945384 Like on Twitter 13519638352094945386 Twitter 1351963835209494538

Retweet on Twitter Societe Francaise De Virologie Retweeted

Avatar Eric Topol@EricTopol·

I spoke w/ @segal_eran (a leading light in the pandemic) today in prep @PMWCintl on Israel's situation.
3 key points:
—B.1.1.7 is now dominant there, ~50%, posing a big challenge for containment
—Status is improving 👍👇
—Single (1st) vaccine dose not as impactful as expected

Reply on Twitter 1351967589686259717 Retweet on Twitter 1351967589686259717135 Like on Twitter 1351967589686259717311 Twitter 1351967589686259717

Avatar Societe Francaise De Virologie @SFV_France·

A l attention des trolls et autres pseudo comptes : la SFV est pour (vrais) virologues +(vrais) scientifiques +(vrais) amoureux des sciences. Mais vous pouvez adherer pour 50E/an avec en plus un abonnemt 1 an a Virologie pour enfin apprendre la vraie virologie.

Reply on Twitter 1352010288816644097 Retweet on Twitter 1352010288816644097 Like on Twitter 13520102888166440972 Twitter 1352010288816644097

Avatar Societe Francaise De Virologie @SFV_France·

Excellent thread from @trvrb

Trevor Bedford@trvrb

Important new study by Wibmer et al (https://www.biorxiv.org/content/10.1101/2021.01.18.427166v1) of neutralization by convalescent sera on wildtype vs 501Y.V2 variant viruses circulating in South Africa. It shows that mutations present in 501Y.V2 result in reduced neutralization capacity. 1/10

Reply on Twitter 1352005925255733250 Retweet on Twitter 1352005925255733250 Like on Twitter 13520059252557332502 Twitter 1352005925255733250

Article Catégorie

Actualité
COVID-19
Evènement
Grand Public
JFV
Offre d'emploi
Uncategorized

Contact

Société Française de Virologie (SFV)
Institut Pasteur
25-28 rue du Dr. Roux
75015 Paris

contact@sfv-virologie.org
Restons connectés
Abonnez-vous à nos listes de diffusion

Quick Links

Qui sommes-nous ?
La revue Virologie
Les Journées Francophones de Virologie
Informations Légales

Special Covid-19

Public expert
Grand public
Espace soignant
Media

Copyright ©2020 Société Française de Virologie. All Rights Reserved.

Nous utilisons des cookies pour vous garantir la meilleur expérience sur notre site web. En poursuivant votre navigation sur notre site, vous validez leur utilisation.
Modifiez vos préférences cookies OK

Politique de confidentialité

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Nécessaire

Toujours activé

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non nécessaire

Non nécessaire

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.